Filing Analysis
🔍 Auditor Change
Filed Jun 27, 2025
🟠 HIGH
Cell Source, Inc. announced the resignation of Marcum LLP as its independent registered public accounting firm and the appointment of CBIZ CPAs P.C. as its new auditor. This change follows a transaction where CBIZ acquired Marcum's attest business.
🚩 Red Flags
- Going concern language: Previous audit reports for fiscal years ended December 31, 2023, and 2022 contained an explanatory paragraph relating to substantial doubt about the Company's ability to continue as a going concern.
- Auditor change combined with historical going concern warnings.
📋 Key Facts
- Marcum LLP resigned as the independent auditor effective June 26, 2025.
- CBIZ CPAs P.C. has been engaged as the new independent registered public accounting firm for the year ended December 31, 2024.
- The company confirmed there were no disagreements with Marcum regarding accounting principles or auditing procedures.
- Marcum's previous audit reports (FY 2022 and FY 2023) included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
💸 Securities Offering
Filed Apr 09, 2024
🟡 MEDIUM
Cell Source, Inc. completed a private offering of 8% Convertible Notes totaling $4,760,170 on March 22, 2024. The notes are convertible into Series C Convertible Preferred Stock at a price of $7.50 per share.
🚩 Red Flags
- Potential future dilution from the conversion of notes and exercise of warrants.
- The warrant exercise price ($1.25) is significantly lower than the note conversion price ($7.50), suggesting potential downward pressure on stock price if warrants are exercised.
📋 Key Facts
- Completed private offering of 8% Convertible Notes on March 22, 2024.
- Aggregate principal amount of notes sold: $4,760,170.
- Conversion price for Series C Convertible Preferred Stock: $7.50 per share.
- Issued warrants to purchase 4,321,926 shares of common stock at an exercise price of $1.25 per share.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.